Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 51
· · ~ · ~ References Ballance, R., Pogany, J., and Forstner, H. 1992. The World's Pharmaceutical Industries. An International Perspective on Innovation, Competition and Policy. Prepared for United Nations Industrial Development Organization (UNIDO). United Kingdom: Edward Elgar. Bosanquet, N., and Trigg, A. 1993. Policy on Licit Substances: The Case of Tobacco. In Normand, C., and Vaughan, J. P., eds., Europe without Frontiers: The Implications for Health. Chichester: John Wiley & Sons, pp. 29~298. Brilliant, L. B. 1985. The Management of Smallpox Eradication in India. Ann Arbor: University of Michigan Press. Brown, P. 1997. The WHO Strikes Mid-Life Crisis. New Scientiest 153:12. CISET (Committee on International Science, Engineering, and Technology). 1995. Global Microbial Threats in the 1990s. Report of the NSTC Committee on International Science, Engineering, and Technology (CISET) Working Group on Emerging and Re-Emerging Infectious Diseases. Washington, D.C.: National Science and Technology Council. Counts, D. C., Brown, J., and Campbell, J. C. 1992. Sanctions and Sanctuary: Cultural Perspectives on the Beating of Wives. Boulder, Colo.: Westview. CSPA (Center for the Study of Policy Attitudes). 1995. Americans and Foreign Aid. A Study of American Public Attitudes. A Poll Conducted by the Program on International Policy Attitudes, a joint program of the Center for the Study of Policy Attitudes and the Center for International and Security Studies at Maryland. Baltimore: University of Maryland. Desjarlais, R., Eisenberg, L., Good, B., and Kleinman, A. 1995. World Mental Health. New York: Oxford University Press. DiMasi, J. A. 1995. Success Rates for New Drugs Entering Clinical Testing in the United States. Clinical Pharmacology & Therapeutics 58: 1-14. The Economist. 1996. Pharmaceuticals: Drug Trafficking. The Economist 341~7996~:65-66. Finkelman, J. 1992. Medio, Salud y Turismo. In: Turismo y Salud en Mexico. Mexico City: OPS, pp. 43-51. Frenk, J. 1995. Comprehensive Policy Analysis for Health System Reform. Health Policy 32:257-277. Frenk, J., and Gomez-Dantes, O. 1995. La Integracion Global y la Salud. Nexos 1995 215:61-65. Frenk, J., Bobadilla, J. L., Sepulveda, J., and Lopez-Cervantes, M. 1989. Health Transition in Middle-Income Countries: New Challenges for Health Care. Health Policy and Planning 4:29-39. Garrett, L. 1996. The Return of Infectious Disease. Foreign Affairs January/February:66-79. IOM (Institute of Medicine). 1979. Pharmaceutical Innovation and the Needs of Developing Countries. Washington, D.C.: National Academy Press. 51

OCR for page 51
52 AMERICA 'S VITAL INTERESTIN GLOBAL HEALTH IOM. 1992a. Emerging Infections: Microbial Threats to Health in the United States. Washington, D.C.: National Academy Press. IOM. 1992b. Technology and Health Care in an Era of Limits. Washington, D.C.: National Academy Press. IOM. 1995a. Health Systems in an Era of Globalization. Washington, D.C.: National Academy Press. IOM. 1996a. Global Health in Transition A Synthesis. Washington, D.C.: National Academy Press. IOM. 1996b. In Her Lifetime: Female Morbidity and Mortality in Sub-Saharan Africa. Washington, D.C.: National Academy Press. IOM. 1996c. Vaccines Against Malaria: Hope in a Gathering Storm. Washington, D.C.: National Academy Press. IOM. 1996d. Contraceptive Research and Development: Looking to the Future. Washington, D.C.: National Academy Press. Kaplan, D. E., and Marshall, A. 1996. The Cult at the End of the World. New York: Crown. Levinson, D. 1989. Family Violence in Cross-Cultural Perspective. Newbury Park, Calif.: Sage. Linden, E. 1996. The Exploding Cities of the Developing World. Foreign Affairs January/February: 52~5. Lippman, T. W. 1997. Clinton to Seek U.N. Dues Fund, Higher Foreign Affairs Budget. Washington Post, January 14; Sect. A: 13. Mann, J., and Tarantola, D., editors. 1996. AIDS in the World II. New York: Oxford University Press. McGuinness, M. J. 1994. Free Trade and Occupational Health Policy: An Argument for Health and Safety Across the North American Workplace. Salud Publica de Mexico 36:578-596. Messner, S. 1989. Economic Discrimination and Societal Homicide Rates: Further Evidence on the Cost of Inequality. American Sociological Review 54:597~11. Murray, C. J. L., and Lopez, A. D. 1996. Global Burden of Disease and Injury, Vol. 1. Boston: Harvard University Press. NAS (National Academy of Sciences). 1995. Allocating Federal Funds for Science and Technology. Washington, D.C.: National Academy Press. NRC (National Research Council). 1996. Summary Report 1995: Doctorate Recipients from U.S. Universities. Washington, D.C.: National Academy Press. OECD (Organization for Economic Cooperation and Development). 1996. OECD News Release, SG/COM/NEWS96~63), 11 June 1996. Paris: OECD Communications Division. OTA (Office of Technology and Assessment). 1996. Pharmaceutical R&D: Costs, Risks and Rewards, (OTA-H-523~. Washington, D.C.: U.S. Government Printing Office. PAHO (Pan American Health Organization). 1992. Pro Salute Novi Mundi: A History of the Pan American Health Organization. Washington, D.C. Shay, J. 1994. Achilles in Vietnam: Combat Trauma and the Undoing of Character. New York: Touchstone. Toole, M. J. 1995. Mass Population Displacement A Global Public Health Challenge. Infectious Disease Clinics of North America 9~2~:353-366. UNDP (United Nations Development Program). 1991. Human Development Report. New York: Oxford University Press. UNESCO (United Nations Educational, Scientific, and Cultural Organization). 1996. World Science Report. Paris: UNESCO.

OCR for page 51
REFERENCES 53 UNICEF (United Nations Children's Fund). 1994. Summary of UNICEF Study A Commercial Perspective of Vaccine Supply, conducted by Mercer Management and Consulting Company, New York. U.S. Congress. Annual Congressional Presentations. 1994. U.S. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight. Hearing to Review Federal and State Expenditures for the Purchase of Children 's Vaccines. 97th Cong., 2nd sees., 1982. Washington Post, Kaiser Family Foundation, and Harvard University. 1996. Reality Check: The Politics of Mistrust. Why Don't Americans Trust the Government? Washington Post 29 January February 1996. WHO (World Health Organization). 1992. Basic Documents, 39th Edition. Geneva. WHO. 1994. Renewing the Health-for-All Strategy. Elaboration of a Policy for Equity, Solidarity and Health. Geneva. WHO. 1996a. Investing in Health Research and Development. Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. Geneva. WHO. 1996b. World Health Report. Fighting Disease, Fostering Development. Report of the Director-General. Geneva. WHO. 1996c. UNAIDS. End 1996 global estimates for HIV prevalence. UNAIDS/SG/96039-4. Press materials for World AIDS Day 1996, released 26 November 1996. Geneva: UNAIDS World Bank. 1993. World Development Report 1993: Investing in Health. New York: Oxford University Press.

OCR for page 51